AxoGen Executive and Leadership Team

Karen Zaderej, the President, Chief Executive Officer & Chairman at AxoGen, directs the company's overarching strategy and corporate governance. Overseeing all business operations, Zaderej ensures the successful development and commercialization of AxoGen's surgical solutions for peripheral nerve injuries. This leadership role involves guiding the company's expansion across North America, Europe, and international markets, driving innovation in nerve grafts, connectors, and protectors. By fostering strategic partnerships and maintaining a strong focus on patient outcomes, Karen Zaderej significantly impacts the company's market position and financial performance. The Chairman's responsibilities include setting the long-term vision and ensuring alignment with the board of directors, solidifying AxoGen's commitment to advancing medical technology in nerve repair.

Lindsey Hartley, the Chief Financial Officer at AxoGen, manages all financial operations and fiscal strategy. Overseeing budgeting, forecasting, and financial reporting, Hartley ensures the company's financial health and supports its growth initiatives. This critical role involves managing capital allocation, investor relations, and financial compliance across all markets, including North America and Europe. By optimizing financial resources and driving fiscal discipline, Lindsey Hartley directly contributes to the sustainable expansion of AxoGen's surgical solutions portfolio. The Chief Financial Officer's leadership ensures robust financial planning, enabling continued investment in research and development for peripheral nerve repair technologies.

Jens Kemp, the Chief Marketing Officer at AxoGen, leads all marketing and commercial strategies. Overseeing brand development and market penetration, Kemp drives the adoption of AxoGen's innovative surgical solutions for peripheral nerve injuries across key regions. This role involves shaping market perception and communicating the value of products like the Avance Nerve Graft and AxoGuard Nerve Protector to surgeons and medical facilities. By executing targeted campaigns and fostering strong customer relationships, Jens Kemp significantly enhances market reach and revenue growth. The Chief Marketing Officer's expertise ensures effective positioning of AxoGen's comprehensive portfolio, including diagnostic tools, to meet the evolving needs of the peripheral nerve repair sector.

Ivica Ducic, the Chief Medical Officer at AxoGen, provides critical medical and scientific leadership. Overseeing clinical strategy and medical affairs, Ducic ensures the efficacy and safety of AxoGen's surgical solutions for peripheral nerve injuries. This role involves guiding clinical research, engaging with the medical community, and translating scientific insights into product development for nerve grafts and protectors. By championing evidence-based medicine and fostering innovation, Ivica Ducic directly supports the advancement of peripheral nerve repair techniques. The Chief Medical Officer's expertise is vital in validating the clinical utility of diagnostic tools like the AcroVal system and driving the company's mission to improve patient outcomes.